ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Follow-Up Questions
Asep Medical Holdings Inc のCEOは誰ですか？
Dr. Robert Hancock は Asep Medical Holdings Inc の Chief Executive Officer で、2021 から在籍しています。
SEPSF の株価パフォーマンスは？
SEPSF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Asep Medical Holdings Inc の主な事業テーマや業界は？
Asep Medical Holdings Inc は N/A 業界、セクターは N/A に属しています。
